The Pharmacological Guide to Haloperidol

$82.00

Amor Harland (Editor)

Series: Pharmacology – Research, Safety Testing and Regulation
BISAC: MED071000

Haloperidol is the most common neuroleptic drugs associated with a range of side effects caused by interactions with other drugs. In The Pharmacological Guide to Haloperidol, the authors review cases that report common pharmacodynamic and pharmacokinetic drug interactions of haloperidol in vivo.
Next, this compilation investigates methods for the determination of haloperidol in body fluids such as blood, urine and cerebral spinal fluid. Several techniques discussed include magnetic resonance spectroscopy, spectrophotometry and high performance liquid chromatography.
Also included is a description of haloperidol derivatives and their applications as antimicrobial agents, vasodilators and calcium channel blockers. Additionally, haloperidol derivatives that have potential applications for improving cardiac function and reducing oxidative stress are also addressed.
The authors present some studies which use functional magnetic resonance imaging to study aspects of haloperidol on facial expressions. Emotion processing is often notable in neurodegenerative diseases such as schizophrenia and evaluated in cerebral blood flow response in diseased patients.
The following chapter focuses on a literature analysis of the use of haloperidol, with studies indicating a potential limit for haloperidol efficacy; values above this limit don’t appear to provid any supplementary clinical improvement.
Lastly, the authors provide a review of studies that have used magnetic resonance imaging to monitor haloperidol in vivo. Applications of 1H and 19F MRI in drug monitoring are discussed and a list of relevant studies is presented.

Clear

Details

Table of Contents

Preface

Chapter 1. Haloperidol Interactions
(Dorota Bartusik-Aebisher, David Aebisher and Zuzanna Bober, Faculty of Medicine, University of Rzeszów, Rzeszów, Poland)

Chapter 2. Determinations of Haloperidol in Body Fluids
(Dorota Bartusik-Aebisher, David Aebisher and Zuzanna Bober, Faculty of Medicine, University of Rzeszów, Rzeszów, Poland)

Chapter 3. Medical Applications of Haloperidol Derivatives
(David Aebisher, Dorota Bartusik-Aebisher and Łukasz Ożóg, Faculty of Medicine, University of Rzeszów, Rzeszów, Poland)

Chapter 4. A Pharmacological fMRI Study of Facial Expressions during Haloperidol Treatment
(Dorota Bartusik-Aebisher, David Aebisher and Adrian Truszkiewicz, Faculty of Medicine, University of Rzeszów, Rzeszów, Poland)

Chapter 5. The Use of fMRI to Identify Biomarkers during Haloperidol Treatment
(David Aebisher, Dorota Bartusik-Aebisher and Adrian Truszkiewicz, Faculty of Medicine, University of Rzeszów, Rzeszów, Poland)

Chapter 6. Applications of 1H and 19F MRI to Monitor Haloperidol
(David Aebisher, Dorota Bartusik-Aebisher and Łukasz Ożóg, Faculty of Medicine, University of Rzeszów, Rzeszów, Poland)

Index

Additional information

Binding

,